{"id":12107,"date":"2025-07-15T17:13:08","date_gmt":"2025-07-15T17:13:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/12107\/"},"modified":"2025-07-15T17:13:08","modified_gmt":"2025-07-15T17:13:08","slug":"biotechnology-market-size-expected-to-surpass-usd-5-71-trillion-by-2034-biologics-regenerative-therapies-chromatography-and-tissue-engineering-in-focus","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/12107\/","title":{"rendered":"Biotechnology Market Size Expected to Surpass USD 5.71 Trillion by 2034: Biologics, Regenerative Therapies, Chromatography and Tissue Engineering in Focus"},"content":{"rendered":"

The global biotechnology market size<\/a> is projected
\nto surpass USD 5.71 trillion by 2034, driven by breakthroughs in biologics,
\ntissue engineering, regenerative therapies, and chromatography. With a strong
\n13.9% CAGR (2025-2034), the industry is rapidly evolving across healthcare,
\npharma, and agriculture, fueling demand for personalized, data-driven solutions
\nworldwide. <\/p>\n

In
\nterms of revenue, the biotechnology market was estimated at USD 1,550 billion
\nin 2024 and is expected to be worth approximately USD 5,71o billion by 2034. Biotechnology
\nis a branch of science that has the ability to create products by utilizing
\nbiological systems, microorganisms, or elements. <\/p>\n

\u201cWith AI revolutionizing drug discovery<\/a> and tissue engineering
\nprogressing rapidly<\/a>, the biotechnology market
\nis entering a golden era,\u201d said Deepa Pandey, Principal Consultant at
\nPrecedence Research.<\/p>\n

<\/p>\n

Note: This report is readily
\navailable for immediate delivery. We can review it with you in a meeting to
\nensure data reliability and quality for decision-making.<\/p>\n

\ud83d\udce5 Download Sample Pages for
\nInformed Decision-Making \ud83d\udc47 https:\/\/www.precedenceresearch.com\/sample\/1450<\/a><\/p>\n

Market Overview and Industry Potential<\/p>\n

From Labs to Life: Biotechnology Transforms Everyday Solutions <\/p>\n

The
\nbiotechnology market is expected to see steady growth owing to the increased
\nneed for products and technologies that use organisms to improve human life in
\nthe current period. Moreover, biology can be applied in a wide applications
\nsuch as agricultural improvements, medical breakthroughs, and environmental solutions
\nas per the recent industry observations. Also, genetic engineering, cell therapies<\/a>, and biologic drugs are
\nplaying a pivotal role in the development of the industry standards in recent
\nyears. <\/p>\n

Also
\nRead \ud83d\udc49 How Generative AI is Revolutionizing
\nDrug Discovery and Biology<\/a><\/p>\n

Biotechnology Market Highlights:<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nThe
\nglobal biotechnology market was valued at approximately USD 1,550 billion in
\n2024.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nIt is
\nprojected to reach nearly USD 5,710 billion by 2034.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nThe
\nmarket is expected to grow at a notable CAGR of 13.90% from 2025 to 2034.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nNorth America led the global market by holding 37.42% of market
\nshare in 2024.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nAsia Pacific is poised to grow at a double digit CAGR of 14.8%
\nfrom 2025 to 2034.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nBy application, the bio-pharmacy segment contributed the largest
\nmarket share of 42% in 2024.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nBy application, the bioinformatics<\/a> segment is
\ngrowing at a solid CAGR of 13.2% from 2025 to 2034.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nBy technology, the tissue engineering and regeneration
\nsegment captured the biggest market share of 19.17% in 2024.<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
\nBy technology, the chromatography segment is expanding at a strong
\nCAGR of 15.1% 2025 to 2034.<\/p>\n

Learn
\nMore About This Market \ud83d\udc49<\/a> https:\/\/www.precedenceresearch.com\/biotechnology-market<\/a><\/p>\n

Key Trends to Watch:<\/p>\n

AI-powered drug discovery platforms gaining FDA
\n traction
\n Expansion of precision medicine targeting oncology
\n and rare diseases
\n CRISPR and gene editing tools entering late-stage
\n trials
\n Biotech venture funding reaching new highs in Asia<\/p>\n

What
\nis the Upcoming Opportunity for the Biotechnology Market?<\/p>\n

Biologics
\nReshape the Pharmaceutical Landscape with Targeted Solutions <\/p>\n

The
\nsudden surge in biologic drugs is likely to create significant opportunities
\nfor manufacturers in the coming years. Moreover, the individuals are increasingly
\npreferring personalized treatments and targeted drugs, which can provide a huge
\nconsumer base to the manufacturers, as the biologic drugs are well known for their
\nspecific and targeted treatments. Also, the manufacturers can create a
\ncollaboration with pharmaceutical<\/a> companies, which is
\nlikely to provide long-term profit margins as per the future industry
\nexpectations. <\/p>\n

Also
\nRead \ud83d\udc49 Pharmaceutical AI Market to Skyrocket
\nat 27% CAGR Through 2034<\/a><\/p>\n

Commercial Highlight: Blockbuster biologics
\nlike Humira and Keytruda have surpassed $20B in annual sales, showcasing the
\nprofitability and demand of this biotech segment. <\/p>\n

What
\nis the Challenge for Biotechnology Market?<\/p>\n

Costly
\nTrails and Complex Formulations Challenge Market Expansion <\/p>\n

The
\ncomplexity of the drug formations and high initial cost for the research and
\ndevelopment activities are anticipated to hinder the industry’s potential in
\nthe coming years. Moreover, this high cost can create growth barriers for the
\nnew entrants and mid-size businesses during the forecast period. Also, the
\nstricter regulation of drug development can reflect the product launch delays
\nin the coming years, as per the recent market environment observation. <\/p>\n

Emerging Risk: Biotech patent cliffs and evolving IP law
\nin the U.S. and EU may further challenge new entrants and raise litigation
\nrisks across regions. <\/p>\n

Biotechnology
\nMarket Report Coverage:<\/p>\n

Report
\n Coverage<\/p>\n

Details<\/p>\n

CAGR from 2025 to 2034<\/p>\n

13.90%<\/p>\n

Market Size in 2024<\/p>\n

USD 1.55 Trillion<\/p>\n

Market Size in 2025<\/p>\n

USD 1.77 Trillion<\/p>\n

Market Size by 2034<\/p>\n

USD 5.71 Trillion<\/p>\n

U.S. Market 2024<\/p>\n

USD\u202f277.7\u202fBillion<\/p>\n

U.S. Market by 2034 (biotech)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n

USD\u202f1,028.1\u202fBillion<\/p>\n

U.S. CAGR 2025-2034<\/p>\n

14%<\/p>\n

Base <\/p>\n

2024<\/p>\n

Forecast Years<\/p>\n

2025 to 2034<\/p>\n

AI in Biotech \u2013 2024 Market Size\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n

USD\u202f4.70\u202fBillion<\/p>\n

AI in Biotech \u2013 Forecast Growth<\/p>\n

CAGR of 19.3%, reaching approx. USD\u202f27.4\u202fbillion by 2034<\/p>\n

Leading Region Market<\/p>\n

North America ~37.4% market share in 2024<\/p>\n

Fastest Growing Market<\/p>\n

Asia Pacific (projected CAGR of 14.8%)<\/p>\n

Segments Covered<\/p>\n

Application, Technology, and Region<\/p>\n

Application \u2013 Top Segment 2024<\/p>\n

Biopharmaceuticals \u2013 42% market share in 2024<\/p>\n

Application \u2013 High\u2011Growth Segment\u00a0 <\/p>\n

Bioinformatics \u2013 CAGR of 13.2% through forecast<\/p>\n

Technology \u2013 Largest Segment 2024<\/p>\n

Tissue engineering & regeneration \u2013 19.17% share<\/p>\n

Technology \u2013 Fastest Growing Tech<\/p>\n

Chromatography \u2013 CAGR of 15.1% projected<\/p>\n

Regions Covered<\/p>\n

North America, Europe, Asia Pacific, Latin America, Middle East
\n and Africa<\/p>\n

Key Players<\/p>\n

Lonza, AstraZeneca, Pfizer Inc., Gilead Sciences Inc., F.
\n Hoffmann-La Roche Ltd., Biogen, CELGENE Corporation, Sanofi, Abbott, Novartis
\n AG.<\/p>\n

Set up a meeting at your convenience to get more insights
\ninstantly<\/a>\ud83d\udc49\u00a0https:\/\/www.precedenceresearch.com\/schedule-meeting<\/a>
\ud83e\uddea Case Study: Biotechnology
\nMarket Outlook and Strategic Trends (2025\u20132034)<\/p>\n

Executive
\nSummary:<\/p>\n

The
\nglobal biotechnology market was valued at USD 1.55 trillion in 2024 and is
\nprojected to hit USD 5.71 trillion by 2034, expanding at a solid CAGR of 13.9%.
\nThis growth reflects the accelerated adoption of advanced technologies such as
\ntissue engineering, biologics, AI-assisted drug discovery, and chromatography.
\nAs the industry evolves, biotechnology is poised to influence healthcare,
\nagriculture, and environmental solutions at scale.<\/p>\n

Market
\nDynamics:<\/p>\n

–
\n**Innovation in Biologics**: Demand for biologic and personalized
\ntreatments is reshaping the pharmaceutical landscape.<\/p>\n

–
\n**AI in Drug Discovery**: Biotech companies increasingly deploy AI for
\nfaster, more accurate development pipelines.<\/p>\n

–
\n**Regenerative Therapies**: Tissue engineering and stem cell therapies
\nlead in addressing chronic diseases and organ repair.<\/p>\n

Regional
\nInsights:<\/p>\n

–
\n**North America** led with a 37.42% market share in 2024 due to robust
\nR&D investment, regulatory support, and major biotech hubs.<\/p>\n

–
\n**Asia Pacific** is the fastest-growing region, driven by demographic
\nstrength, healthcare expansion, and biotech innovation from countries like
\nChina and India.<\/p>\n

Segmental
\nHighlights:<\/p>\n

–
\n**Bio-pharmacy** held the largest market share (42% in 2024), boosted by
\ndemand for targeted, safer therapies.<\/p>\n

–
\n**Chromatography** is the fastest-growing technology segment (15.1%
\nCAGR), playing a crucial role in drug validation and biosample processing.<\/p>\n

–
\n**Bioinformatics** is also surging, supporting data-heavy research needs
\nin genomics and proteomics.<\/p>\n

Challenges:<\/p>\n

–
\nHigh R&D costs, complex regulations, and patent-related uncertainties
\nremain key barriers for new entrants and mid-sized firms.<\/p>\n

Future
\nOutlook:<\/p>\n

Between
\n2025 and 2034, the biotechnology industry is expected to further diversify across
\ntherapeutic and industrial applications, supported by cross-disciplinary
\ninnovation and global investment in biotech infrastructure. As the market
\nbecomes increasingly data-driven, the integration of AI, precision medicine<\/a>, and sustainable
\nbio-solutions will define the next era of competitive advantage.<\/p>\n

For questions or customization requests, please reach out to us @ sales@precedenceresearch.com<\/a> | +1 804 441
\n9344<\/p>\n

How Big is the U.S. Biotechnology Market Size?<\/p>\n

According
\nto Precedence Research, the U.S. biotechnology market size was USD 277.67
\nbillion in 2024 and is expected to rise from USD 316.41 billion in 2025 to USD
\n1,028.07 billion by 2034. The market reflects a CAGR of 14% from 2025 to 2034.<\/p>\n

<\/p>\n

Is Early Tech Adoption the Secret to North America\u2019s Biotech Success?<\/p>\n

North America held the dominant share of the biotechnology market
\nin 2024, owing to having a capable and advanced
\nresearch base with higher investment in the current period. <\/a>Moreover, the
\nregion has the presence of major biotech companies, which have provided a
\nsignificant advantage to the market in recent years. <\/p>\n

Also, the early adoption of high-end technologies by healthcare
\nprofessionals is anticipated to create huge potential for the market in the coming
\nyears. Furthermore, the strong regulatory bodies like NIH and others are increasingly
\npushing the industry growth by maintaining the regulatory standards of the
\ndrugs in the region. <\/p>\n

<\/p>\n

Note: This report is
\nreadily available for immediate delivery. We can review it with you in a
\nmeeting to ensure data reliability and quality for decision-making.<\/p>\n

\ud83d\udcca Analyze Before You Invest
\n\u2013 Request Sample Pages \ud83d\udc47 https:\/\/www.precedenceresearch.com\/sample\/1450<\/a><\/p>\n

Is Asia Pacific on the Brink of a Biotech Boom Fuelled by Demographic Power? <\/p>\n

\u00a0<\/p>\n

Asia Pacific is expected to expand notably during the forecast
\nperiod, owing to ongoing technology advancements and increased healthcare funding in
\nthe current period. Moreover, the regional countries such as India, China, and
\nothers have seen a heavy healthcare infrastructural upgrade in recent years. <\/p>\n

Furthermore, the large populations of the region are expected to
\nplay a huge role in the market progress in upcoming years, as the need for
\neffective drugs and strong healthcare infrastructure is expected to increase,
\nas per recent observations.\u00a0 <\/p>\n

Biotechnology Market Segmentation Analysis:<\/p>\n

By Application Analysis:<\/p>\n

Why did the bio-pharmacy segment dominate the market in 2024?<\/p>\n

The bio-pharmacy segment held the largest share of the
\nbiotechnology market in 2024, owing to the
\nincreased need for biological drugs in the current period. <\/a>Moreover, the increased
\nadoption of personalized treatments s severely contributed to the segment
\ngrowth in recent years. Also, having fewer side effects compared to the
\ntraditional chemical-based drugs, these drugs have gained major industry
\nattention in the past few years. Also, showing positive efficacy in treating life-threatening
\ndiseases like cancer, autoimmune diseases, and diabetes, the biological drugs have
\ncaptured a significant industry share in recent years. <\/p>\n

<\/p>\n

On the other hand, the bio-agriculture segment is expected to
\ngrow significantly during the forecast period due to the increased need for
\nanalyzing and managing a huge amount of biological data structures for the
\nagricultural sector. Moreover, the increased demand for genetic testing and genomics<\/a> for better
\ncrop yield is seen to promote the segment\u2019s growth. The desire for clean label
\nproducts such as demand for organic ingredients is boosting the segment\u2019s
\ngrowth. As multiple sectors emphasize over addressing environmental concerns,
\nthe bio-agriculture segment will boom with both improved efficacy and
\nscalability. <\/p>\n

By End User Analysis:<\/p>\n

How Tissue Engineering and Regeneration Maintain Their
\nDominance in the Current Industry?<\/p>\n

The tissue engineering and
\nregeneration <\/a>segment held the largest share of the biotechnology market in
\n2024, akin to its transformative potential in treating injuries and diseases by
\nrepairing or replacing damaged tissues and organs. This technology combines cells,
\nengineering methods, and biomaterials to create
\nartificial organs<\/a> or stimulate the body to heal itself. It’s widely used in
\nreconstructive surgeries, wound healing, orthopedics, and even organ
\nregeneration. With a growing number of patients suffering from chronic
\nconditions and organ failure, the demand for regenerative solutions is
\nincreasing. <\/p>\n

Furthermore, innovations in stem cell
\nresearch<\/a> and 3D bioprinting are
\nenhancing the success and application of tissue regeneration<\/a>. Governments and medical
\ninstitutes are also funding regenerative medicine projects due to their
\nlong-term cost-effectiveness and patient benefits. The aging population and
\nscarcity of organ donors further make this segment vital. As a result, tissue
\nengineering and regeneration technologies have become key pillars in modern
\nbiotechnology.<\/p>\n

Also
\nRead \ud83d\udc49 Tissue Engineering Market: From USD\u202f11.7B
\nin 2024 to USD\u202f36.3B by 2034 (12% CAGR)<\/a><\/p>\n

On the other hand, the chromatography segment is expected to grow
\nat a notable rate. It’s
\nan essential tool for analyzing, separating, and purifying biological samples
\nin research and production. In biotechnology, especially in drug development
\nand quality control, chromatography is widely used to ensure the purity and
\neffectiveness of biologics like vaccines<\/a>, enzymes<\/a>, and proteins<\/a>. With increasing demand
\nfor high-precision biological products and tighter regulatory standards,
\nmanufacturers are turning to advanced chromatography techniques to meet quality
\nbenchmarks. <\/p>\n

It’s
\nalso used in genomic studies, proteomics, food safety testing<\/a>, and environmental
\nbiotech. As biopharmaceutical<\/a> manufacturing becomes
\nmore complex and requires higher efficiency, the need for reliable analytical
\ntechnologies like chromatography grows. Innovations such as miniaturized
\nsystems, automated platforms, and faster processing tools are making
\nchromatography even more accessible and productive. These benefits are expected
\nto drive its dominance in future biotechnology applications across various
\nindustries.<\/p>\n

Related Topics You May Find
\nUseful:<\/a><\/p>\n

\u27a2 Biotechnology Instruments Market: https:\/\/www.precedenceresearch.com\/biotechnology-instruments-market<\/a><\/p>\n

\u27a2 Biotechnology Contract Manufacturing Market: https:\/\/www.precedenceresearch.com\/biotechnology-contract-manufacturing-market<\/a><\/p>\n

\u27a2 Biotechnology Reagents and Kits Market: https:\/\/www.precedenceresearch.com\/biotechnology-reagents-and-kits-market<\/a><\/p>\n

\u27a2\u00a0 Biotechnology
\nand Pharmaceutical Services Outsourcing Market: https:\/\/www.precedenceresearch.com\/biotechnology-and-pharmaceutical-services-outsourcing-market<\/a><\/p>\n

\u27a2 Life Science
\nMarket: https:\/\/www.precedenceresearch.com\/life-science-market<\/a><\/p>\n

\u27a2 DNA Sequencing
\nMarket: https:\/\/www.precedenceresearch.com\/dna-sequencing-market<\/a><\/p>\n

\u27a2 Precision
\nFermentation Market: https:\/\/www.precedenceresearch.com\/precision-fermentation-market<\/a><\/p>\n

\u27a2 Mammalian Cell
\nFermentation Technology Market: https:\/\/www.precedenceresearch.com\/mammalian-cell-fermentation-technology-market<\/a><\/p>\n

\u27a2 Nanotechnology
\nMarket: https:\/\/www.precedenceresearch.com\/nanotechnology-market<\/a><\/p>\n

Top 10 Companies in Biotechnology Market<\/p>\n

\u00a0\ud83d\udd38<\/a>Lonza<\/p>\n

\ud83d\udd38AstraZeneca<\/p>\n

\ud83d\udd38Pfizer Inc.<\/p>\n

\ud83d\udd38Gilead Sciences Inc.<\/p>\n

\ud83d\udd38F. Hoffmann-La Roche Ltd.<\/p>\n

\ud83d\udd38Biogen<\/p>\n

\ud83d\udd38CELGENE Corporation<\/p>\n

\ud83d\udd38Sanofi<\/p>\n

\ud83d\udd38Abbott<\/p>\n

\ud83d\udd38Novartis AG<\/p>\n

What is Going Around the Globe?<\/p>\n

\ud83d\udd39<\/a> In 2025,\u00a0the Indian government
\nintroduced a new initiative to support biotech startups in India. The newly
\nlaunched initiatives are named BioSaarthi as per the rect report published by the
\ngovernment. Also, the initiative has a structured mentor-mentee engagement for
\nthis six-month program.\u00a0 (Source- https:\/\/www.mountsinai.org<\/a>)<\/p>\n

\ud83d\udd39 In 2025,\u00a0mAbxience received
\nthe approval of the denosumab biosimilars from the European Commission. These
\napproved biosimilars include Denbrayce and Izamby, as per the report published
\nby the company recently. (Link- https:\/\/www.prnewswire.com<\/a>)<\/p>\n

Biotechnology Market Segmentation:<\/p>\n

By Application<\/p>\n

\u2022 Bio-pharmacy<\/p>\n

\u2022 Bio-industries<\/p>\n

\u2022 Bio-services<\/p>\n

\u2022 Bio-agriculture<\/p>\n

\u2022 Bio-informatics<\/p>\n

By Technology<\/p>\n

\u2022 Fermentation<\/p>\n

\u2022 Tissue Engineering and Regeneration<\/p>\n

\u2022 Polymerase Chain Reaction (PCR) Technology<\/p>\n

\u2022 Nanobiotechnology<\/p>\n

\u2022 Chromatography<\/p>\n

\u2022 Deoxyribonucleic Acid (DNA) Sequencing<\/p>\n

\u2022 Cell-Based Assay<\/p>\n

\u2022 DNA Sequencing<\/p>\n

\u2022 Others<\/p>\n

By Geography\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n<\/p>\n

\u2022 North America<\/p>\n

\u2022 Europe<\/p>\n

\u2022 Asia Pacific<\/p>\n

\u2022 Latin America<\/p>\n

\u2022 Middle East & Africa (MEA)<\/p>\n

Thanks for reading you can
\nalso get individual chapter-wise sections or region-wise report versions such
\nas North America, Europe, or Asia Pacific.<\/a><\/p>\n

\ud83d\udcca<\/a> Everything
\nYou Need in One Report \u2013 Click to Buy Now<\/a> \ud83d\udc47 https:\/\/www.precedenceresearch.com\/checkout\/1450<\/a><\/p>\n

You
\ncan place an order or ask any questions, please feel free to contact at <\/a>sales@precedenceresearch.com<\/a> | +1
\n804 441 9344<\/p>\n

Stay Ahead with Precedence Research
\nSubscriptions<\/a><\/p>\n

Unlock
\nexclusive access to powerful market intelligence, real-time data, and
\nforward-looking insights, tailored to your business. From trend tracking to
\ncompetitive analysis, our subscription plans keep you informed, agile, and
\nahead of the curve.<\/p>\n

Browse
\nOur Subscription Plans@ https:\/\/www.precedenceresearch.com\/get-a-subscription<\/a><\/p>\n

————————————————————————————————————————–<\/p>\n

Biotechnology
\nMarket FAQs (2025\u20132034)<\/p>\n

1. What is
\nthe size of the biotechnology market?
\u27a2 The global biotechnology
\nmarket is projected to reach USD 5.71 trillion by 2034, growing from USD 1.55 trillion in 2024 at a 13.9% CAGR.<\/p>\n

2. What\u2019s
\ndriving the growth of the biotechnology market?
\u27a2 Key drivers include biologics, AI in drug discovery, tissue engineering, precision medicine, and growing demand across
\nhealthcare and agriculture.<\/p>\n

3. Which
\nregion leads the biotechnology market?
\u27a2 North America led with a 37.42% share in 2024, backed by advanced
\nR&D, strong regulation, and major biotech players.<\/p>\n

4. Which
\nregion is growing the fastest?
\u27a2 Asia Pacific is the fastest-growing
\nregion with a 14.8%
\nCAGR,
\ndriven by population growth, biotech investments, and healthcare expansion.<\/p>\n

5. What is
\nthe U.S. biotechnology market size?
\u27a2 The U.S. market was USD 277.7 billion in 2024 and is projected to hit USD 1,028.1 billion by 2034.<\/p>\n

6. Which
\napplication dominates the market?
\u27a2 Bio-pharmacy led with a 42% share in 2024, due to high demand for
\nbiologic and personalized drugs.<\/p>\n

7. What is
\nthe top biotechnology technology segment?
\u27a2 Tissue engineering &
\nregeneration
\nheld the largest share, while chromatography is the fastest-growing segment (15.1%
\nCAGR).<\/p>\n

8. How is
\nAI impacting biotech?
\u27a2 AI accelerates drug discovery, genomic analysis, and precision therapeutics, with its biotech market
\nexpected to reach USD
\n27.4 billion by 2034.<\/p>\n

9. What
\nchallenges affect the biotechnology market?<\/p>\n

\u27a2 Key challenges include high R&D costs, complex regulations, and IP\/patent issues for new entrants.<\/p>\n

10. Who
\nare the top biotech companies?
\u27a2 Leading players include Pfizer, Roche, AstraZeneca,
\nLonza, Biogen, Gilead, Sanofi, and Novartis<\/p>\n

————————————————————————————————————————–<\/p>\n

About
\nUs<\/p>\n

Precedence
\nResearch is a global market intelligence and consulting powerhouse, dedicated
\nto unlocking deep strategic insights that drive innovation and transformation.
\nWith a laser focus on the dynamic world of
\nlife sciences<\/a>,
\nwe specialize in decoding the complexities of cell and
\ngene therapy<\/a>,
\ndrug development, and oncology markets<\/a>, helping our clients stay
\nahead in some of the most cutting-edge and high-stakes domains in healthcare.
\nOur expertise spans across the biotech and pharmaceutical ecosystem, serving
\ninnovators, investors, and institutions that are redefining what\u2019s possible in regenerative medicine<\/a>, cancer care, precision
\ntherapeutics, and beyond.<\/p>\n

Web:
\nhttps:\/\/www.precedenceresearch.com<\/a><\/p>\n

Our
\nTrusted Data Partners:<\/p>\n

Towards Healthcare<\/a> | Statifacts<\/a> | Nova One Advisor<\/a><\/p>\n

Get
\nRecent News: <\/p>\n

https:\/\/www.precedenceresearch.com\/news<\/a><\/p>\n

For
\nLatest Update Follow Us:<\/p>\n

LinkedIn<\/a> | Facebook<\/a> | Twitter<\/a><\/p>\n

\u00a0<\/p>\n

.<\/p>\n

\u00a0<\/p>\n